Grants for Public housing authorities - Health

This grant provides funding for researchers to explore the complex interactions between the brain and immune system in the context of HIV and substance use disorders, aiming to identify new therapeutic targets and improve understanding of related neurological issues.

Reissue of RFA-MH-20-128 This Funding Opportunity Announcement (FOA) solicits applications to develop standards that describe experimental protocols that are being conducted as part of the BRAIN Initiative. It is expected that applications will solicit community input at all stages of the process. It is recommended that the first step of standard development will involve sharing data between different key groups in the experimental community in order to ensure that the developing standard will cover the way that all of those groups are collecting data. The developed standard is expected to be made widely available.

This funding opportunity supports the development of innovative therapies to counteract the effects of Botulinum Neurotoxin, targeting researchers and organizations focused on advancing treatments for this serious health threat.

This funding opportunity provides financial support to organizations working in Namibia to improve health information systems and enhance public health programs related to HIV, tuberculosis, and other health threats.

This funding opportunity supports early postdoctoral fellows from diverse backgrounds in cancer research, providing mentorship and training to help them address health disparities and advance their careers in the field.

This funding opportunity is designed to support research and interventions that reduce HIV risk among individuals affected by alcohol use, focusing on innovative prevention strategies and their implementation in various communities.

This(NOFO) aims to innovate, implement, and evaluate approaches to One Health laboratory diagnostic network optimization and specimen transport in Liberia. This multi-component NOFO is designed to address the inter-dependence of a comprehensive, resource-mapped, accredited national and sub-national laboratory network, the physical transportation architecture required to transfer network commodities (namely human, animal, and environmental specimens) point-to-point, and the optimization of digital communication, information, and supply chain systems necessary to sustain the network itself.

Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological or neuromuscular disorders that fall under the NINDS mission. Therapeutic agents include small molecules, biologics or biotechnology-derived products. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network or other translational programs.

This funding opportunity supports a variety of organizations in developing innovative technologies to identify and target senescent cells, which could lead to new treatments for age-related diseases.

This funding opportunity supports researchers exploring the use of microorganisms, like bacteria and viruses, to develop innovative methods for cancer imaging, diagnosis, and treatment.

This Notice of Funding Opportunity (NOFO) invites applications for Cystic Fibrosis (CF) Research and Translation Core Centers. CF Research and Translation Core Centers are designed to support both basic and clinical research on Cystic Fibrosis. CF Research and Translation Core Centers support three primary research-related activities: Research Core services; a Pilot and Feasibility program; and an Administrative Core with an enrichment program. Core Centers provide shared resources to support research to develop and test new therapies for CF and to foster collaborations among institutions with a strong existing research base in CF. The NIDDK currently supports seven CF Research and Translation Centers located at institutions with documented programs of research excellence in basic and clinical CF Research. Information about the currently funded CF Research and Translation Centers may be found at: https://www.niddk.nih.gov/research-funding/research-programs/cystic-fibrosis-research-translation-centers or https://www.cysticfibrosiscenters.org/.

This grant provides funding for Au.D. audiologists to conduct rigorous biomedical research and complete their doctoral dissertations, fostering the development of independent researchers in the field.

The Cooperative Agreement to Support Navigators in Federally-facilitated Exchanges (Funding Opportunity) will enable recipients to operate as Exchange Navigators in states with a Federally facilitated Exchange (FFE), as authorized by the Affordable Care Act (ACA). Each year, the Centers for Medicare Medicaid Services (CMS) makes grant awards to organizations who serve as Navigators in FFE states. Navigators help consumers prepare applications to establish eligibility and enroll in coverage through the Exchanges, and help determine whether consumers potentially qualify for insurance affordability programs. They also provide outreach and education to raise awareness about the Exchanges. As trusted community partners, Navigators are required to provide targeted assistance to underserved and vulnerable populations within the Exchange service area, which is critical to improving access to health care coverage for communities that often experience a disproportionate burden of disease. In furtherance of the Biden Administrations goals on ensuring access to and expanding affordable and high-quality health care coverage and improving health equity, Navigators are well positioned to reach historically underserved and vulnerable communities, especially those who continue to face significant health disparities. Navigators operate year-roundincreasing awareness among the remaining uninsured about the coverage options available to them, helping consumers find affordable coverage that meets their needs, and assisting consumers beyond the enrollment process to ensure theyre equipped with the tools and resources needed to utilize and maintain their health coverage all year. The increased funding available to applicants through this Funding Opportunity will enable FFE Navigators to further expand their reach, with a renewed focus on outreach to diverse, underserved, and vulnerable communities.

This funding opportunity provides financial support for research projects that explore and improve crisis response services for suicide prevention, particularly targeting diverse and underserved populations.

This funding opportunity supports neurologists and neurosurgeons in the NINDS intramural program as they transition to independent research-focused faculty positions at academic institutions.

This funding opportunity supports research teams in developing and testing new treatments for aging-related conditions, excluding neurodegenerative diseases, through preclinical studies and early-phase human trials.

This funding opportunity supports innovative research projects that develop new tools and methods for measuring children's language development, particularly focusing on diverse cultural and linguistic backgrounds, to improve early identification of those needing interventions.

This funding opportunity supports innovative research projects that explore the effective use and sharing of genomic information in clinical care for diverse populations, regardless of their racial, ethnic, or socioeconomic backgrounds.

This funding opportunity supports researchers in developing and testing innovative devices for diagnosing and treating disorders of the nervous system through small clinical studies and safety assessments.

This grant provides funding for researchers to explore how diet and lipid metabolism influence tumor growth and progression, encouraging innovative studies that connect nutrition science with cancer biology.